skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Government Regulation remover assunto: Survival Analysis remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil
Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil

Batista, Thales Paulo; Sabat, Bernardo David; Melo, Paulo Sérgio V.; Miranda, Luiz Eduardo C.; Fonseca-Neto, Olival Cirilo L.; Amorim, Américo Gusmão; Lacerda, Cláudio Moura

Clinics; v. 66 n. 1 (2011); 57-64

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo 2011-01-01

Acesso online

2
Primary care physician continuity, survival, and end‐of‐life care intensity
Primary care physician continuity, survival, and end‐of‐life care intensity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Primary care physician continuity, survival, and end‐of‐life care intensity

Hung, Peiyin ; Cramer, Laura D. ; Pollack, Craig E. ; Gross, Cary P. ; Wang, Shi‐Yi

Health services research, 2022-08, Vol.57 (4), p.853-862 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
3
Federal actions to incentivise state adoption of 0.08 g/dL blood alcohol concentration laws
Federal actions to incentivise state adoption of 0.08 g/dL blood alcohol concentration laws
Material Type:
Artigo 		Adicionar ao Meu Espaço

Federal actions to incentivise state adoption of 0.08 g/dL blood alcohol concentration laws

Tung, Gregory J ; Vernick, Jon S ; Stuart, Elizabeth A ; Webster, Daniel W ; Gielen, Andrea C

Injury prevention, 2017-10, Vol.23 (5), p.309-313 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
4
Randomised trial of two nicotine patch protocols distributed through a state quitline
Randomised trial of two nicotine patch protocols distributed through a state quitline
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomised trial of two nicotine patch protocols distributed through a state quitline

Burns, Emily K ; Hood, Nancy E ; Goforth, Emma ; Levinson, Arnold H

Tobacco control, 2016-03, Vol.25 (2), p.218-223 [Periódico revisado por pares]

England: BMJ Publishing Group

Texto completo disponível

Citações Citado por
5
The Role of the U.S. Food and Drug Administration Review Process: Clinical Trial Endpoints in Oncology
The Role of the U.S. Food and Drug Administration Review Process: Clinical Trial Endpoints in Oncology
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Role of the U.S. Food and Drug Administration Review Process: Clinical Trial Endpoints in Oncology

McKee, Amy E. ; Farrell, Ann T. ; Pazdur, Richard ; Woodcock, Janet

The oncologist (Dayton, Ohio), 2010-01, Vol.15 (S1), p.13-18 [Periódico revisado por pares]

Durham, NC, USA: AlphaMed Press

Texto completo disponível

Citações Citado por
6
Is a government-regulated rehabilitation guideline more effective than general practitioner education or preferred-provider rehabilitation in promoting recovery from acute whiplash-associated disorders? A pragmatic randomised controlled trial
Is a government-regulated rehabilitation guideline more effective than general practitioner education or preferred-provider rehabilitation in promoting recovery from acute whiplash-associated disorders? A pragmatic randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Is a government-regulated rehabilitation guideline more effective than general practitioner education or preferred-provider rehabilitation in promoting recovery from acute whiplash-associated disorders? A pragmatic randomised controlled trial

Côté, Pierre ; Boyle, Eleanor ; Shearer, Heather M ; Stupar, Maja ; Jacobs, Craig ; Cassidy, John David ; Carette, Simon ; van der Velde, Gabrielle ; Wong, Jessica J ; Hogg-Johnson, Sheilah ; Ammendolia, Carlo ; Hayden, Jill Alison ; van Tulder, Maurits ; Frank, John W

BMJ open, 2019-01, Vol.9 (1), p.e021283-e021283 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
7
Booster Seat Laws and Fatalities in Children 4 to 7 Years of Age
Booster Seat Laws and Fatalities in Children 4 to 7 Years of Age
Material Type:
Artigo 		Adicionar ao Meu Espaço

Booster Seat Laws and Fatalities in Children 4 to 7 Years of Age

MANNIX, Rebekah ; FLEEGLER, Eric ; MEEHAN, William P ; SCHUTZMAN, Sara A ; HENNELLY, Kara ; NIGROVIC, Lise ; LEE, Lois K

Pediatrics (Evanston), 2012-12, Vol.130 (6), p.996-1002 [Periódico revisado por pares]

Elk Grove Village, IL: American Academy of Pediatrics

Texto completo disponível

Citações Citado por
8
Viewpoint: A method to estimate the cost in lives of ethics board review of biomedical research
Viewpoint: A method to estimate the cost in lives of ethics board review of biomedical research
Material Type:
Artigo 		Adicionar ao Meu Espaço

Viewpoint: A method to estimate the cost in lives of ethics board review of biomedical research

Whitney, S. N. ; Schneider, C. E.

Journal of internal medicine, 2011-04, Vol.269 (4), p.396-402 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
9
Special Health Care Needs of Infants Born at the Limits of Viability
Special Health Care Needs of Infants Born at the Limits of Viability
Material Type:
Artigo 		Adicionar ao Meu Espaço

Special Health Care Needs of Infants Born at the Limits of Viability

STEPHENS, Bonnie E ; TUCKER, Richard ; VOHR, Betty R

Pediatrics (Evanston), 2010-06, Vol.125 (6), p.1152-1158 [Periódico revisado por pares]

Elk Grove Village, IL: American Academy of Pediatrics

Texto completo disponível

Citações Citado por
10
Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues
Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues
Material Type:
Artigo 		Adicionar ao Meu Espaço

Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues

Chakravarty, Aloka ; Sridhara, Rajeshwari

Statistical methods in medical research, 2008-10, Vol.17 (5), p.515-518 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (14)
  2. Revistas revisadas por pares (12)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (14)
  2. magazinearticle  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2008  (2)
  2. 2008Até2009  (3)
  3. 2010Até2011  (5)
  4. 2012Até2016  (3)
  5. Após 2016  (3)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Batista, T
  2. Amorim, A
  3. Melo, P
  4. Lacerda, C
  5. Sabat, B

Neste Assunto:

  1. Government Regulation
  2. Survival Analysis
  3. Government Regulation
  4. Survival Analysis
  5. Humans

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.